SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-054336
Filing Date
2023-11-03
Accepted
2023-11-03 16:40:06
Documents
2
Period of Report
2023-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1596
2 POA DOCUMENT poa.txt EX-24 3611
  Complete submission text file 0001209191-23-054336.txt   6620
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Issuer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address KALEIDO BIOSCIENCES, INC. 65 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Long Alison S (Reporting) CIK: 0001891712 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39536 | Film No.: 231376997